Anthera Pharmaceuticals, Inc. (ANTH) Earnings
|
Expand Research on ANTH
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -10.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -5.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/24  |
Q324 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/11/24 |
Q324 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/4/24 | Q324 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/19/24 | Q224 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/24 | Q224 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/7/24 | Q224 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/9/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
